T0	Participants 56 93	patients with coronary artery disease
T1	Participants 247 291	patients with coronary artery disease (CAD).
T2	Participants 382 555	26 males with CAD before and after treatment with quinapril (10 mg day-1; n=13) or atorvastatin (40 mg day-1; n=13) for 4 weeks and an additional 4 weeks of combined therapy
T3	Participants 1224 1236	CAD patients